Sex steroids and breast density predict breast cancer risk

Article

Both circulating sex steroid levels and mammographic density are strong and independent predictors of breast Ca risk in postmenopausal women. . .

Both circulating sex steroid levels and mammographic density are strong and independent predictors of breast cancer risk in postmenopausal women, according to the results of a nested case-control study.

Using a cohort of 253 women with breast cancer and 520 controls within the Nurses' Health Study, researchers found that women in the highest quartile for mammographic density had almost four times the risk for breast cancer as women in the lowest quartile (RR 3.8; 95% CI, 2.2–6.6; Ptrend<0.001). Adjusting the analysis for circulating estradiol or circulating testosterone made little change (RR 3.9; 95% CI, 2.2–6.0; Ptrend<0.001; and RR 4.1; 95% CI, 2.3–7.2, Ptrend<0.001, respectively). Women with high levels of circulating estradiol or circulating testosterone had about twice as high a risk for developing breast cancer as women with low levels, before and after adjustment for mammographic density (RR 2.4; 95% CI, 1.4–4.0; and RR 2.0; 95% CI, 1.2–3.1, respectively). Women who had both high levels of plasma testosterone and very dense breasts were at six times the risk for breast cancer as women in the lowest tertiles for both (RR 6.0; 95% CI, 2.6–14.0). Figures were similar for women with both high circulating estradiol and mammographic density (RR 4.1; 95% CI, 1.7–9.8).

Tamimi RM, Byrne C, Colditz GA, et al. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99:1178-1187.

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.